EU Herbal Product History-Of-Use Requirement May Be Flexible – EMEA
This article was originally published in The Tan Sheet
The EMEA may be flexible in implementing a provision of the Herbal Medicinal Products Directive that requires herbal medicines to demonstrate a 30-year history of use prior to being sold in the EU, according to a representative of the health authority
You may also be interested in...
The Committee for Herbal Medicinal Products (CHMP) should be able to exempt herbal products from the minimum time of use requirements, according to the European Commission
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Perrigo promotes in pricing, planning